CAFARO, ALESSIA
 Distribuzione geografica
Continente #
EU - Europa 1.060
AS - Asia 10
Totale 1.070
Nazione #
IT - Italia 1.060
CN - Cina 10
Totale 1.070
Città #
Genoa 825
Vado Ligure 174
Rapallo 45
Genova 12
Bordighera 4
Beijing 2
Totale 1.062
Nome #
A novel LC–MS/MS-based method for the diagnosis of ADA2 deficiency from dried plasma spot 93
Dose optimization and target attainment of vancomycin in children 73
Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children 69
A Novel LC-MS/MS Method for Therapeutic Drug Monitoring of Baricitinib in Plasma of Pediatric Patients 68
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method 62
Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy 62
Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity 61
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations 61
Altered plasma levels of apixaban in major gastrointestinal tract surgery: A case report and review of the literature 51
Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients 49
A LC-MS/MS METHOD FOR THE QUANTIFICATION OF CENOBAMATE USING VOLUMETRIC ADSORPTIVE MICROSAMPLING (VAMS) 48
A NOVEL LC–MS/MS METHOD FOR THERAPEUTIC DRUG MONITORING OF APIXABAN IN PLASMA AND DRIED PLASMA SPOT: A POTENTIAL TOOL FOR THE OPTIMIZATION OF DIRECT ANTICOAGULANT DRUGS IN SPECIAL POPULATIONS 43
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica 43
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD 42
Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography-tandem mass spectrometry method 40
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method” 38
Therapeutic drug monitoring of medical cannabis in pediatrics: The experience of Giannina Gaslini Institute|Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini 35
Innovative LC-MS/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy 34
Inter-Subject Variability in Clinical Response to Elexacaftor/Tezacaftor/Ivacaftor Therapy: The Role of Therapeutic Drug Monitoring 34
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices 31
Indications for the harmonization of the therapeutic intervals of antibacterial drugs|Indicazioni per l'armonizzazione degli intervalli terapeutici dei farmaci antibatterici 29
Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment 27
Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Plasma of Pediatric and Young Adult Patients 19
Totale 1.112
Categoria #
all - tutte 4.867
article - articoli 4.098
book - libri 0
conference - conferenze 666
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 0 0 0 0 0 2 0 4 3 2 5
2022/202367 5 5 0 1 7 5 0 5 14 5 15 5
2023/2024108 4 5 9 12 4 17 4 6 3 13 12 19
2024/2025637 17 35 53 25 23 42 44 120 53 70 89 66
2025/2026284 156 29 45 54 0 0 0 0 0 0 0 0
Totale 1.112